BCM
BOLD

Beryl Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Beryl Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-550,426
Closed -$32.9M – 62
2019
Q4 		$32.9M Buy
+550,426
New +$20.7M 5.31% 6

Beryl Capital Management's BOLD Position: Q1 2020 in Review

Beryl Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 550,426 shares — an estimated $32.9M sold.

Beryl Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $32.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Beryl Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Beryl Capital Management sold 550,426 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $32.9M.
  • Beryl Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Beryl Capital Management's Audentes Therapeutics, Inc position peaked at $32.9M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Beryl Capital Management's 13F filing for Q1 2020, filed 15 May 2020.